Antarctic Sea Sponge: New Weapon to Fight Malaria

by Adeline Dorcas on  September 13, 2019 at 2:55 PM Tropical Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

Sponge discovered from the Antarctic sea may open up new avenues for better malaria treatment, reports a new study. The findings of the study are published in ACS' Journal of Natural Products.
Antarctic Sea Sponge: New Weapon to Fight Malaria
Antarctic Sea Sponge: New Weapon to Fight Malaria

The frigid waters of the Antarctic may yield a treatment for a deadly disease that affects populations in some of the hottest places on earth. Current medications for that scourge -- malaria -- are becoming less effective as drug resistance spreads. But, researchers report that a peptide they isolated from an Antarctic sponge shows promise as a lead for new therapies.

Show Full Article


Some 219 million cases of malaria were reported worldwide in 2017, according to the World Health Organization, with 435,000 people having died from the disease in that year. Symptoms begin with fever and chills, which can be followed by severe anemia, respiratory distress and organ failure. The parasite responsible for malaria is transmitted to people through mosquito bites. It spends some of its lifecycle first in the liver, where it reproduces, and then it moves into the blood.

Conventional treatments based on artemisinin and its derivatives hold the parasite in check when it is in patients' blood, but the parasites are increasingly becoming resistant to these medications. One solution is to attack the organism at an earlier stage in its lifecycle, when there are fewer parasites, and resistance might not have developed yet -- namely, when it's in the liver. In their search for a suitable pharmaceutical weapon, Bill J. Baker and colleagues turned to sponges, which rely on an array of chemical defenses to fight off predators.

The team screened a collection of natural products extracted from a Southern Ocean sponge known as Inflatella coelosphaeroides. One compound, which they dubbed friomaramide, blocked infection and development of the malaria parasite Plasmodium falciparum in liver cells in a culture dish as effectively as primaquine, one of the few existing liver-stage treatments.

Friomaramide is also nontoxic to the liver cells themselves. The researchers determined that the compound is a linear peptide with a distinctive structure, which they say makes it a promising framework for producing new leads for malaria treatment.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive